Chen Yang Luke Acquires Shares in 111, Inc.
Chen Yang Luke purchased 413,168 shares of 111, Inc. on May 12, 2026.
Key Points
- Chen Yang Luke bought 413,168 shares of 111, Inc. on May 12, 2026, without a planned transaction code.
- 111, Inc. trades on NasdaqGM with a market cap of $40.2 million and a forward P/E of 32.64.
- Renaissance Technologies increased its 111, Inc. stake by 300 shares, while UBS Group AG reduced its holdings by 203 shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On May 12, 2026, Chen Yang Luke acquired 413,168 shares of 111, Inc., trading under the ticker YI on the NasdaqGM. This insider purchase was not part of a pre-planned trading scheme.
What Changed in Chen Yang Luke's 111, Inc. Position
Chen Yang Luke's acquisition of 413,168 shares marks a significant personal investment in 111, Inc. The transaction was recorded without a specified purchase price, indicating a strategic move to increase his stake in the company.
Other Institutional Activity in 111, Inc.
Renaissance Technologies LLC increased its holdings in 111, Inc. by 300 shares, bringing its total to 13,014 shares valued at approximately $84,851. Serenus Wealth Advisors, LLC, however, trimmed its position by 64 shares, now holding 4,320 shares worth around $321,334. Citigroup Inc. newly acquired 207 shares valued at $1,341, while UBS Group AG significantly reduced its stake by 203 shares, leaving it with 100 shares valued at $652.
111, Inc. Stock Up 30.2%
Shares of NasdaqGM:YI traded near $4.57. The company has a market capitalization of $40.2 million and a forward P/E ratio of 32.64, with a beta of 0.609. The stock's 52-week range spans from a low of $2.48 to a high of $11.17. Its 50-day moving average is $5.88, while the 200-day moving average stands at $5.40. The company maintains a current ratio of 1.084 and a quick ratio of 0.366, with a debt-to-equity ratio of 150.925.
Insider Buying and Selling at 111, Inc.
In addition to Chen Yang Luke's purchase, several other insider transactions occurred. Sun Jian David sold 58,800 shares on June 15, 2026, at an average price of $0.23. On the same day, Chen Yang Luke sold 44,000 shares at the same price. Earlier, on June 12, 2026, Chen Yang Luke sold 49,920 shares. These transactions were not planned under Rule 10b5-1 trading plans.
About 111, Inc.
111, Inc. is a healthcare company based in Shanghai, China, operating an integrated online and offline platform. It provides supply chain services to pharmaceutical companies, along with online retail and wholesale pharmacy services. The company offers a range of healthcare products and services, including drugs, supplements, and personal care items. Founded in 2010, 111, Inc. serves various stakeholders in the healthcare market, including pharmacies and medical professionals.
Bottom Line
Chen Yang Luke's purchase of 413,168 shares of 111, Inc. suggests confidence in the company's potential. Investors keep a close watch on insider transactions as they can provide insights into a company's future prospects. Remember, this information is based on past transactions and may not reflect current positions.
Get 111, Inc. alerts
New 13F filings, insider trades, and analyst moves on $YI, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.